Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med. 2023 Jan 19;388(3):214-227. doi: 10.1056/NEJMoa2213082.
N Engl J Med. 2023.
PMID: 36652353
Free PMC article.
Clinical Trial.
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial.
Gayed J, Diya O, Lowry FS, Xu X, Bangad V, Mensa F, Zou J, Xie X, Hu Y, Lu C, Cutler M, Belanger T, Cooper D, Koury K, Anderson AS, Türeci Ö, Şahin U, Swanson KA, Modjarrad K, Gurtman A, Kitchin N; C4591054 Study Group.
Gayed J, et al. Among authors: bangad v.
Vaccines (Basel). 2024 Jan 24;12(2):118. doi: 10.3390/vaccines12020118.
Vaccines (Basel). 2024.
PMID: 38400102
Free PMC article.
Item in Clipboard
Minimally invasive treatment for idiopathic chondrolysis of the hip: analysis of forty-one cases.
Patwardhan S, Rapole S, Vinayak U, Shyam A, Sancheti PK, Bangad V.
Patwardhan S, et al. Among authors: bangad v.
Int Orthop. 2024 Jun;48(6):1627-1634. doi: 10.1007/s00264-024-06137-0. Epub 2024 Mar 19.
Int Orthop. 2024.
PMID: 38502336
Item in Clipboard
Cite
Cite